|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- | Trial initiation date: Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 7, 2013
P2, N=41, Completed, Sponsor: Oneness Biotech Co., Ltd.
Initiation date: May 2008 --> Dec 2008
- | Trial completion: Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 7, 2013
P2, N=41, Completed, Sponsor: Oneness Biotech Co., Ltd.
Initiation date: May 2008 --> Dec 2008 Recruiting --> Completed
- |||||||||| New P3 trial: Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers (clinicaltrials.gov) - Jul 1, 2013
P3, N=225, Completed, Sponsor: Shire Regenerative Medicine, Inc.
- gevokizumab (S 78989) / Novartis
New P2 trial: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum (clinicaltrials.gov) - Jun 18, 2013
P2, N=8, Active, not recruiting, Sponsor: XOMA (US) LLC
- || New P3 trial: Reference Nurse Program for Pressure Ulcers in Primary Care (clinicaltrials.gov) - Jun 12, 2013
P3, N=124, Active, not recruiting, Sponsor: Basque Health Service
- Enrollment change: The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates- A Placebo Controlled Trial (clinicaltrials.gov) - May 19, 2013
P=N/A, N=26, Completed, Sponsor: Changi General Hospital
Recruiting --> Completed N=40 --> 26
- | Trial completion: The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates- A Placebo Controlled Trial (clinicaltrials.gov) - May 19, 2013
P=N/A, N=26, Completed, Sponsor: Changi General Hospital
N=40 --> 26 Not yet recruiting --> Completed
- New P1 trial: Preliminary Testing of New Treatment for Chronic Leg Wounds (clinicaltrials.gov) - May 19, 2013
P1, N=15, Completed, Sponsor: University of Pennsylvania
- | cenplacel (PDA-002) / Celularity
New P1 trial: Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU (clinicaltrials.gov) - May 19, 2013
P1, N=24, Recruiting, Sponsor: Celgene Corporation
- |||||||||| New P3 trial: Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (clinicaltrials.gov) - May 13, 2013
P3, N=440, Recruiting, Sponsor: Smith & Nephew, Inc.
- |||||||||| New P3 trial: STRIDE 2: Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers (clinicaltrials.gov) - May 7, 2013
P3, N=633, Recruiting, Sponsor: Derma Sciences, Inc.
- Trial completion: Preliminary Testing of New Treatment for Chronic Leg Wounds (clinicaltrials.gov) - May 7, 2013
P1, N=24, Completed, Sponsor: University of Pennsylvania
Not yet recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: SACRESS: Prevention of Sacral Pressure Ulcers With Preventive Dressings (clinicaltrials.gov) - Apr 30, 2013
P=N/A, N=914, Recruiting, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- plerixafor / Generic mfg.
Trial initiation date: Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 24, 2013
P1, N=27, Not yet recruiting, Sponsor: New York University School of Medicine
Not yet recruiting --> Recruiting Initiation date: Jan 2012 --> Apr 2014
- ||||| Enrollment change: Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 23, 2013
P2/3, N=130, Completed, Sponsor: Ogenix Corporation
Initiation date: Jan 2012 --> Apr 2014 N=180 --> 130
- |||||||||| New P3 trial: STRIDE 5: Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use (clinicaltrials.gov) - Apr 23, 2013
P3, N=200, Recruiting, Sponsor: Derma Sciences, Inc.
- ||||||| Trial completion: Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 23, 2013
P2/3, N=130, Completed, Sponsor: Ogenix Corporation
N=180 --> 130 Recruiting --> Completed
- |||||| Enrollment open: STRIDE 5: Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use (clinicaltrials.gov) - Apr 22, 2013
P3, N=200, Recruiting, Sponsor: Derma Sciences, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||||| Fiblast (trafermin) / Kaken Pharma
Trial completion: The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study (clinicaltrials.gov) - Apr 21, 2013
P3, N=207, Completed, Sponsor: Olympus Biotech Corporation
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||||| Fiblast (trafermin) / Kaken Pharma
Trial completion: The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study (clinicaltrials.gov) - Apr 21, 2013
P3, N=201, Completed, Sponsor: Olympus Biotech Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| New P4 trial: Study of Oasis Ultra in Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 16, 2013
P4, N=100, Active, not recruiting, Sponsor: Healthpoint
- Trial withdrawal: Non-enhanced Magnetic Resonance Angiography of Diabetic Ischemic Lower Limbs (clinicaltrials.gov) - Apr 10, 2013
P=N/A, N=0, Withdrawn, Sponsor: Aarhus University Hospital
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Enrollment change: Non-enhanced Magnetic Resonance Angiography of Diabetic Ischemic Lower Limbs (clinicaltrials.gov) - Apr 10, 2013
P=N/A, N=0, Withdrawn, Sponsor: Aarhus University Hospital
Not yet recruiting --> Withdrawn N=50 --> 0
- |||||||||| New P3 trial: STRIDE 1: Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 10, 2013
P3, N=422, Recruiting, Sponsor: Derma Sciences, Inc.
- |||| Trial completion: Using Santyl on Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 10, 2013
P4, N=55, Completed, Sponsor: Healthpoint
N=50 --> 0 Active, not recruiting --> Completed
- LeukoScan (sulesomab) / Gilead
Trial initiation date: ISEOD: PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=109, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Active, not recruiting --> Completed Initiation date: Jul 2012 --> Oct 2012
- Trial termination: Cast Sores With Waterproof Vs. Standard Cast Padding (clinicaltrials.gov) - Apr 4, 2013
P=N/A, N=84, Terminated, Sponsor: Shriners Hospitals for Children
Recruiting --> Terminated; Staffing changes resulted in the expiration of IRB approval (2/15/12), and recruitment halted (n=84). IRB approval is now current for retrospective analysis.
- Enrollment change: Cast Sores With Waterproof Vs. Standard Cast Padding (clinicaltrials.gov) - Apr 4, 2013
P=N/A, N=84, Terminated, Sponsor: Shriners Hospitals for Children
IRB approval is now current for retrospective analysis. N=190 --> 84
- |||| Trial completion: Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers. (clinicaltrials.gov) - Mar 27, 2013
P4, N=159, Completed, Sponsor: Laboratoires URGO
N=190 --> 84 Recruiting --> Completed
- ||| Enrollment change: Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers. (clinicaltrials.gov) - Mar 26, 2013
P4, N=280, Not yet recruiting, Sponsor: Cytomedix
Recruiting --> Completed N=800 --> 280
- ||||| New P4 trial: AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers (clinicaltrials.gov) - Mar 25, 2013
P4, N=400, Not yet recruiting, Sponsor: Cytomedix
- ||||| New P4 trial: A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers (clinicaltrials.gov) - Mar 21, 2013
P4, N=385, Recruiting, Sponsor: Cytomedix
- New P1/2 trial: PRP-2012: Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers (clinicaltrials.gov) - Mar 21, 2013
P1/2, N=40, Recruiting, Sponsor: Basque Health Service
- ||||| New P4 trial: Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers. (clinicaltrials.gov) - Mar 20, 2013
P4, N=280, Not yet recruiting, Sponsor: Cytomedix
- ||||| New P4 trial: Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 20, 2013
P4, N=380, Recruiting, Sponsor: Cytomedix
- Enrollment change: Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic Foot (clinicaltrials.gov) - Mar 20, 2013
P2, N=96, Completed, Sponsor: University Hospital Ostrava
N=800 --> 280 N=40 --> 96
- Trial completion: Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic Foot (clinicaltrials.gov) - Mar 20, 2013
P2, N=96, Completed, Sponsor: University Hospital Ostrava
N=40 --> 96 Active, not recruiting --> Completed
- || New P2/3 trial: AIRPEDIA: Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management (clinicaltrials.gov) - Mar 17, 2013
P2/3, N=64, Recruiting, Sponsor: University Hospital, Grenoble
- | Trial completion: PUPPAS: Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens (clinicaltrials.gov) - Mar 8, 2013
P3, N=330, Completed, Sponsor: University Hospital Virgen de las Nieves
Active, not recruiting --> Completed Recruiting --> Completed
- Trial termination: RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs (clinicaltrials.gov) - Mar 4, 2013
P4, N=13, Terminated, Sponsor: Celleration, Inc.
Recruiting --> Completed Not yet recruiting --> Terminated; Enrollment delays, business re-allocation of resources
- Enrollment change: RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs (clinicaltrials.gov) - Mar 4, 2013
P4, N=13, Terminated, Sponsor: Celleration, Inc.
Not yet recruiting --> Terminated; Enrollment delays, business re-allocation of resources N=100 --> 13
- || Enrollment change: Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers (clinicaltrials.gov) - Mar 4, 2013
P=N/A, N=208, Recruiting, Sponsor: Celleration, Inc.
N=100 --> 13 N=124 --> 208
- New P2 trial: Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers (clinicaltrials.gov) - Feb 27, 2013
P2, N=50, Recruiting, Sponsor: Professor Stewart Walsh
- Enrollment change: A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=31, Completed, Sponsor: TEI Biosciences Inc.
N=124 --> 208 N=90 --> 31
- | Trial completion: A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=31, Completed, Sponsor: TEI Biosciences Inc.
N=90 --> 31 Active, not recruiting --> Completed
- Trial completion: The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients (clinicaltrials.gov) - Feb 14, 2013
P=N/A, N=40, Completed, Sponsor: Rabin Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- |||||| Enrollment open: Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 (clinicaltrials.gov) - Feb 13, 2013
P3, N=250, Recruiting, Sponsor: Healthpoint
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- Trial termination: Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury (clinicaltrials.gov) - Feb 11, 2013
P2, N=19, Terminated, Sponsor: Healthpoint
Not yet recruiting --> Recruiting Recruiting --> Terminated; Business decision
- Trial termination: Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers (clinicaltrials.gov) - Feb 11, 2013
P4, N=19, Terminated, Sponsor: Hollister Wound Care LLC
Recruiting --> Terminated; Business decision Recruiting --> Terminated; slow accrual
- Enrollment change: Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury (clinicaltrials.gov) - Feb 11, 2013
P2, N=19, Terminated, Sponsor: Healthpoint
Recruiting --> Terminated; slow accrual N=40 --> 19